ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
20.98
-1.08 (-4.90%)
At close: Jul 11, 2025, 4:00 PM
21.00
+0.02 (0.10%)
After-hours: Jul 11, 2025, 6:20 PM EDT
ACADIA Pharmaceuticals Market Cap
ACADIA Pharmaceuticals has a market cap or net worth of $3.51 billion as of July 11, 2025. Its market cap has increased by 36.23% in one year.
Market Cap
3.51B
Enterprise Value
2.89B
1-Year Change
36.23%
Ranking
Category
Stock Price
$20.98
Market Cap Chart
Since May 27, 2004, ACADIA Pharmaceuticals's market cap has increased from $112.80M to $3.51B, an increase of 3,012.81%. That is a compound annual growth rate of 17.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 3.51B | 15.00% |
| Dec 31, 2024 | 3.05B | -40.60% |
| Dec 29, 2023 | 5.14B | 99.41% |
| Dec 30, 2022 | 2.58B | -31.29% |
| Dec 31, 2021 | 3.75B | -55.85% |
| Dec 31, 2020 | 8.50B | 28.98% |
| Dec 31, 2019 | 6.59B | 225.79% |
| Dec 31, 2018 | 2.02B | -45.92% |
| Dec 29, 2017 | 3.74B | 7.07% |
| Dec 30, 2016 | 3.49B | -2.91% |
| Dec 31, 2015 | 3.60B | 13.57% |
| Dec 31, 2014 | 3.17B | 39.50% |
| Dec 31, 2013 | 2.27B | 762.44% |
| Dec 31, 2012 | 263.30M | 361.93% |
| Dec 30, 2011 | 57.00M | 20.76% |
| Dec 31, 2010 | 47.20M | -6.53% |
| Dec 31, 2009 | 50.50M | 51.20% |
| Dec 31, 2008 | 33.40M | -91.84% |
| Dec 31, 2007 | 409.20M | 56.24% |
| Dec 29, 2006 | 261.90M | 13.18% |
| Dec 30, 2005 | 231.40M | 102.63% |
| Dec 31, 2004 | 114.20M | 1.24% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |